Brokerages Anticipate Envista Holdings Co. (NYSE:NVST) Will Announce Quarterly Sales of $634.54 Million

Wall Street brokerages expect Envista Holdings Co. (NYSE:NVST) to announce $634.54 million in sales for the current fiscal quarter, Zacks reports. Five analysts have provided estimates for Envista’s earnings, with estimates ranging from $630.00 million to $638.60 million. Envista posted sales of $732.30 million during the same quarter last year, which suggests a negative year-over-year growth rate of 13.3%. The business is scheduled to report its next earnings results on Wednesday, February 9th.

On average, analysts expect that Envista will report full year sales of $2.53 billion for the current fiscal year, with estimates ranging from $2.49 billion to $2.69 billion. For the next financial year, analysts anticipate that the company will post sales of $2.62 billion, with estimates ranging from $2.60 billion to $2.66 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research analysts that cover Envista.

Envista (NYSE:NVST) last announced its quarterly earnings data on Wednesday, November 3rd. The company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.05. The business had revenue of $607.30 million for the quarter, compared to the consensus estimate of $676.69 million. Envista had a net margin of 13.02% and a return on equity of 9.52%. During the same quarter last year, the company posted $0.48 earnings per share.

NVST has been the topic of a number of recent research reports. Zacks Investment Research upgraded shares of Envista from a “sell” rating to a “hold” rating in a research note on Wednesday, January 5th. Morgan Stanley lifted their price target on shares of Envista from $42.00 to $45.00 and gave the stock an “equal weight” rating in a research note on Friday, January 7th. Finally, Bank of America upgraded shares of Envista from a “neutral” rating to a “buy” rating and decreased their price target for the stock from $49.00 to $48.00 in a research note on Tuesday, October 26th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $49.40.

NVST traded up $0.55 during trading on Friday, reaching $46.31. 2,131,363 shares of the company’s stock were exchanged, compared to its average volume of 1,370,856. Envista has a fifty-two week low of $33.75 and a fifty-two week high of $46.88. The company has a quick ratio of 1.18, a current ratio of 1.39 and a debt-to-equity ratio of 0.22. The business has a 50 day moving average price of $42.71 and a 200 day moving average price of $41.96. The company has a market capitalization of $7.47 billion, a P/E ratio of 22.26, a PEG ratio of 0.63 and a beta of 1.75.

In related news, CEO Amir Aghdaei sold 8,434 shares of Envista stock in a transaction dated Wednesday, December 22nd. The stock was sold at an average price of $44.75, for a total value of $377,421.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Mischa Reis sold 10,016 shares of Envista stock in a transaction dated Thursday, December 23rd. The shares were sold at an average price of $45.00, for a total value of $450,720.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 87,487 shares of company stock valued at $4,020,190. Company insiders own 0.82% of the company’s stock.

Large investors have recently made changes to their positions in the business. Tudor Investment Corp Et Al raised its holdings in Envista by 966.2% during the 2nd quarter. Tudor Investment Corp Et Al now owns 81,223 shares of the company’s stock worth $3,510,000 after purchasing an additional 73,605 shares during the last quarter. Great West Life Assurance Co. Can raised its holdings in Envista by 499.3% during the 2nd quarter. Great West Life Assurance Co. Can now owns 62,469 shares of the company’s stock worth $2,699,000 after purchasing an additional 52,046 shares during the last quarter. Hancock Whitney Corp raised its holdings in Envista by 1.9% during the 3rd quarter. Hancock Whitney Corp now owns 45,064 shares of the company’s stock worth $1,884,000 after purchasing an additional 825 shares during the last quarter. Macquarie Group Ltd. raised its holdings in Envista by 771.4% during the 2nd quarter. Macquarie Group Ltd. now owns 4,015,893 shares of the company’s stock worth $173,527,000 after purchasing an additional 3,555,062 shares during the last quarter. Finally, NEXT Financial Group Inc acquired a new position in shares of Envista during the 3rd quarter worth about $95,000.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, and markets dental products in the United States and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha Bio Tec, Implant Direct, Logon, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Ormco, Insignia, AOA, and Spark brands.

Further Reading: Insider Trading

Get a free copy of the Zacks research report on Envista (NVST)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.